²ÝÁñÉçÇø

Gilead Sciences said Wednesday that preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a 5-day dosage of antiviral drug remdesivir improved and more than half were discharged from the hospital within two weeks.